Temporomandibular Disorders and its Relationship with Fibromyalgia

  • Ana Mirian Velly
  • Hong Chen
  • João R. Ferreira
  • James R. Fricton


Temporomandibular Disorder (TMD) is the second most common musculoskeletal condition resulting in orofacial pain and disability. Although most cases of Temporomandibular Muscle and Joint Disorders (TMJD) are mild and self-limiting, about 10% of TMJD patients develop severe disorders associated with chronic pain and disability. One in two patients seeking care still has pain 5 years later. The treatment of TMD has been an increasing financial burden, with annual U.S. costs doubling in the last decade to $4 billion annually. It has been found that fibromyalgia (FMS) plays a significant role in the persistence of TMD. This chapter reviews the characteristics and the relationship between TMD and FMS, highlighting the importance of this comorbid condition for the management of TMD.


Chronic Fatigue Syndrome Muscle Fiber Type Mechanical Hyperalgesia Pressure Pain Threshold Widespread Pain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



American College of Rheumatology diagnostic criteria


Acid-sensing ion channels


Brain-derived neurotrophic factor






Myofascial pain




Nerve growth factor




Research Diagnostic Criteria


Tender points


Temporomandibular Disorder


Trigger points


  1. Aaron, L. A., & Buchwald, D. (2001a). Fibromyalgia and other unexplained clinical conditions. Current Rheumatology Reports, 3, 116–122.CrossRefPubMedGoogle Scholar
  2. Aaron, L. A., & Buchwald, D. (2001b). A review of the evidence for overlap among unexplained clinical conditions. Annals of Internal Medicine, 134, 868–881.CrossRefPubMedGoogle Scholar
  3. Aaron, L. A., & Buchwald, D. (2003). Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Practice & Research: Clinical Rheumatology, 17, 563–574.CrossRefGoogle Scholar
  4. Aaron, L. A., Burke, M. M., & Buchwald, D. (2000). Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine, 160, 221–227.CrossRefPubMedGoogle Scholar
  5. Adler, G. K., Kinsley, B. T., Hurwitz, S., Mossey, C. J., & Goldenberg, D. L. (1999). Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. The American Journal of Medicine, 106, 534–543.CrossRefPubMedGoogle Scholar
  6. Balasubramaniam, R., de Leeuw, R., Zhu, H., Nickerson, R. B., Okeson, J. P., & Carlson, C. R. (2007). Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 104, 204–216.CrossRefPubMedGoogle Scholar
  7. Bengtsson, A., Henriksson, K. G., Jorfeldt, L., Kagedal, B., Lennmarken, C., & Lindstrom, F. (1986a). Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scandinavian Journal of Rheumatology, 15, 340–347.CrossRefPubMedGoogle Scholar
  8. Bengtsson, A., Henriksson, K. G., & Larsson, J. (1986b). Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis and Rheumatism, 29, 817–821.CrossRefPubMedGoogle Scholar
  9. Berglund, B., Harju, E. L., Kosek, E., & Lindblom, U. (2002). Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain, 96, 177–187.CrossRefPubMedGoogle Scholar
  10. Bradley, L. A., McKendree-Smith, N. L., & Alarcon, G. S. (2000). Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Current Review of Pain, 4, 148–157.CrossRefPubMedGoogle Scholar
  11. Buskila, D. (2001). Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinion in Rheumatology, 13, 117–127.CrossRefPubMedGoogle Scholar
  12. Cimino, R., Michelotti, A., Stradi, R., & Farinaro, C. (1998). Comparison of clinical and psychologic features of fibromyalgia and masticatory myofascial pain. Journal of Orofacial Pain, 12, 35–41.PubMedGoogle Scholar
  13. Clauw, D. J., & Chrousos, G. P. (1997). Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation, 4, 134–153.PubMedGoogle Scholar
  14. Clauw, D. J., & Crofford, L. J. (2003). Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Practice & Research. Clinical Rheumatology, 17, 685–701.CrossRefGoogle Scholar
  15. Cohen, H., Neumann, L., Shore, M., Amir, M., Cassuto, Y., & Buskila, D. (2000). Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism, 29, 217–227.CrossRefPubMedGoogle Scholar
  16. Crofford, L. J., Young, E. A., Engleberg, N. C., Korszun, A., Brucksch, C. B., McClure, L. A., Brown, M. B., & Demitrack, M. A. (2004). Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain, Behavior, and Immunity, 18, 314–325.CrossRefPubMedGoogle Scholar
  17. Dadabhoy, D., Crofford, L. J., Spaeth, M., Russell, I. J., & Clauw, D. J. (2008). Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Research & Therapy, 10, 211.CrossRefGoogle Scholar
  18. Dao, T. T., Reynolds, W. J., & Tenenbaum, H. C. (1997). Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia. Journal of Orofacial Pain, 11, 232–241.PubMedGoogle Scholar
  19. de Abreu, T. C., Nilner, M., Thulin, T., & Vallon, D. (1993). Office and ambulatory blood pressure in patients with craniomandibular disorders. Acta Odontologica Scandinavica, 51, 161–170.CrossRefPubMedGoogle Scholar
  20. Rodriguez de Sotillo, D., Velly, A.M., Hadley, M., Fricton, J.R. (2011). Evidence of oxidative stress in temporomandibular disorders: a pilot study. Journal of Oral Rehabilitation 38(10), 722–728. Google Scholar
  21. DeSantana, J. M., & Sluka, K. A. (2008). Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Current Pain and Headache Reports, 12, 338–343.CrossRefPubMedGoogle Scholar
  22. Desmeules, J. A., Cedraschi, C., Rapiti, E., Baumgartner, E., Finckh, A., Cohen, P., Dayer, P., & Vischer, T. L. (2003). Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis and Rheumatism, 48, 1420–1429.CrossRefPubMedGoogle Scholar
  23. Diatchenko, L., Slade, G., Nackley, A., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S., Shagin, D., Max, M., Makarov, S., & Maixner, W. (2005). Genetic basis for individual variations in pain perception and the develoopment of a chronic pain condition. Human Molecular Genetics, 14, 135–143.CrossRefPubMedGoogle Scholar
  24. Domschke, K., Freitag, C. M., Kuhlenbaumer, G., Schirmacher, A., Sand, P., Nyhuis, P., Jacob, C., Fritze, J., Franke, P., Rietschel, M., Garritsen, H. S., Fimmers, R., Nothen, M. M., Lesch, K. P., Stogbauer, F., & Deckert, J. (2004). Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. The International Journal of Neuropsychopharmacology, 7, 183–188.CrossRefPubMedGoogle Scholar
  25. Drangsholt, M., & LeResche, L. (1999). Temporomandibular Disorders Pain. In I. K. Crombie, P. R. Croft, S. J. Linton, L. LeResche, & M. Von Korff (Eds.), Epidemiology of Pain. Seattle, WA: IASP.Google Scholar
  26. Dubner, R. (1992). Neuronal plasticity in the spinal dorsal horn following tissue inflammation. In R. Inoki, Y. Shigenaga, & M. Tohyama (Eds.), Processing and Inhibition of Nociceptive Information (pp. 35–41). Excerpta medica: Tokyo.Google Scholar
  27. Dubner, R. (61). Hyperalgesia in Response to Injury to Cutaneous and Deep Tissues. In O. Pain, T. Disorders, J. Fricton, & R. Dubner (Eds.), New (pp. 71–1995). York: Raven Press, Ltd.Google Scholar
  28. Dubner, R., & Bennett, G. J. (1983). Spinal and trigeminal mechanisms of nociception. Annual Review of Neuroscience, 6, 381–418.CrossRefPubMedGoogle Scholar
  29. Dworkin, S. F., & LeResche, L. (1992). Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique [Review]. Journal of Craniomandibular Disorders, 6, 301–355.PubMedGoogle Scholar
  30. Dworkin, S. F., LeResche, L., Fricton, J. R., Mohl, N., Sommers, E., & Truelove, E. (1992). Research diagnostic criteria, Part II, Axis I: Clinical TMD Conditions[Review]. Journal of Craniomandibular Disorders, 6, 327–330.Google Scholar
  31. Dworkin, S. F., LeResche, L., Von Korff, M., Truelove, E., & Sommers, E. (1989). Predicting Continued Presence and Level of TMD Pain: An Epidemiologic Study. Journal of Dental Research, 68, 194.Google Scholar
  32. Elam, M., Johansson, G., & Wallin, B. G. (1992). Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain, 48, 371–375.CrossRefPubMedGoogle Scholar
  33. El-Labban, N. G., Harris, M., Hopper, C., & Barber, P. (1990). Degenerative changes in masseter and temporalis muscles in limited mouth opening and TMJ ankylosis. Journal Oral Pathology Medicine, 19, 423–425.CrossRefGoogle Scholar
  34. Enoch, M. A., Xu, K., Ferro, E., Harris, C. R., & Goldman, D. (2003). Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatric Genetics, 13, 33–41.CrossRefPubMedGoogle Scholar
  35. Eriksson, P. O., Lindman, R., Stal, P., & Bengtsson, A. (1988). Symptoms and signs of mandibular dysfunction in primary fibromyalgia syndrome (PSF) patients. Swedish Dental Journal, 12, 141–149.PubMedGoogle Scholar
  36. Eriksson, P. O., & Thornell, L. E. (1983). Histochemical and morphological muscle-fibre characteristics of the human masseter, the medial pterygoid, and the temporal muscles. Archives of Oral Biology, 28, 781–795.CrossRefPubMedGoogle Scholar
  37. Farella, M., Michelotti, A., Steenks, M. H., Romeo, R., Cimino, R., & Bosman, F. (2000). The diagnostic value of pressure algometry in myofascial pain of the jaw muscles. Journal of Oral Rehabilitation, 27, 9–14.CrossRefPubMedGoogle Scholar
  38. Fernandez-de-Las-Penas, C., Galan-Del-Rio, F., Alonso-Blanco, C., Jimenez-Garcia, R., Arendt-Nielsen, L., & Svensson, P. (2010). Referred pain from muscle trigger points in the masticatory and neck-shoulder musculature in women with temporomandibular disorders. The Journal of Pain, 11, 1295–1304.CrossRefPubMedGoogle Scholar
  39. Fricton, J. (1990). Myofascial Pain syndrome: Characteristics and epidemiology. In J. Fricton & E. Awad (Eds.), Advances in Pain Research and Therapy (pp. 107–127). New York: Raven Press.Google Scholar
  40. Fricton, J. R. (2004). The relationship of temporomandibular disorders and fibromyalgia: Implications for diagnosis and treatment. Current Pain and Headache Reports, 8, 355–363.CrossRefPubMedGoogle Scholar
  41. Fricton, J., & Dall’ Arancio, D. (1994). Myofascial pain of the head and neck: Controlled outcome study of an interdisciplinary pain program. Journal of Musculoskeletal Pain, 2, 81–99.CrossRefGoogle Scholar
  42. Fricton, J. R. K. R., & Haley, D. (1982). Myofascial pain syndrome: A review of 164 cases. Oral Surgery, 60, 615–623.CrossRefGoogle Scholar
  43. Fricton, J., Kroening, R., Haley, D., & Siegert, R. (1985). Myofascial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surgery, Oral Medicine, and Oral Pathology, 60, 615–623.CrossRefPubMedGoogle Scholar
  44. Garofalo, J. P., Gatchel, R. J., Wesley, A. L., & Ellis, E., 3rd. (1998). Predicting chronicity in acute temporomandibular joint disorders using the research diagnostic criteria. The Journal of the American Dental Association, 129, 438–447.PubMedGoogle Scholar
  45. Gatchel, R. J., Garofalo, J. P., Ellis, E., & Holt, C. (1996). Major psychological disorders in acute and chronic TMD: an initial examination. The Journal of the American Dental Association, 127, 1365–1374.PubMedGoogle Scholar
  46. Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N., & Turk, D. C. (2007). The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychological Bulletin, 133, 581–624.CrossRefPubMedGoogle Scholar
  47. Ge, H. Y., Wang, Y., Danneskiold-Samsoe, B., Graven-Nielsen, T., & Arendt-Nielsen, L. (2010). The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. The Journal of Pain, 11, 644–651.CrossRefPubMedGoogle Scholar
  48. Gerwin, R. D. (2011). Fibromyalgia tender points at examination sites specified by the American College of Rheumatology criteria are almost universally myofascial trigger points. Current Pain and Headache Reports, 15, 1–3.CrossRefPubMedGoogle Scholar
  49. Giovengo, S. L., Russell, I. J., & Larson, A. A. (1999). Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. The Journal of Rheumatology, 26, 1564–1569.PubMedGoogle Scholar
  50. Giske, L., Vollestad, N. K., Mengshoel, A. M., Jensen, J., Knardahl, S., & Roe, C. (2008). Attenuated adrenergic responses to exercise in women with fibromyalgia–a controlled study. European Journal of Pain, 12, 351–360.CrossRefPubMedGoogle Scholar
  51. Glass, J. M., Lyden, A. K., Petzke, F., Stein, P., Whalen, G., Ambrose, K., Chrousos, G., & Clauw, D. J. (2004). The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. Journal of Psychosomatic Research, 57, 391–398.PubMedGoogle Scholar
  52. Goldenberg, D. L. (2002). Office management of fibromyalgia. Rheumatic Diseases Clinics of North America, 28, 437–446.CrossRefPubMedGoogle Scholar
  53. Gracely, R. H., Geisser, M. E., Giesecke, T., Grant, M. A., Petzke, F., Williams, D. A., & Clauw, D. J. (2004). Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain, 127, 835–843.CrossRefPubMedGoogle Scholar
  54. Granges, G., & Littlejohn, G. (1993). Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis and Rheumatism, 36, 642–646.CrossRefPubMedGoogle Scholar
  55. Guilbaud, G. (1991). Central neurophysiological processing of joint pain on the basis of studies performed in normal animals and in models of experimental arthritis. Canadian Journal of Physiology and Pharmacology, 69, 637–646.CrossRefPubMedGoogle Scholar
  56. Gur, A., Cevik, R., Nas, K., Colpan, L., & Sarac, S. (2004). Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Research & Therapy, 6, R232–238.CrossRefGoogle Scholar
  57. Gursoy, S., Erdal, E., Herken, H., Madenci, E., Alasehirli, B., & Erdal, N. (2003). Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International, 23, 104–107.PubMedGoogle Scholar
  58. Hamaty, D., Valentine, J. L., Howard, R., Howard, C. W., Wakefield, V., & Patten, M. S. (1989). The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study. The Journal of Rheumatology. Supplement, 19, 164–168.PubMedGoogle Scholar
  59. Hamilton, S. P., Slager, S. L., Heiman, G. A., Deng, Z., Haghighi, F., Klein, D. F., Hodge, S. E., Weissman, M. M., Fyer, A. J., & Knowles, J. A. (2002). Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biological Psychiatry, 51, 591–601.CrossRefPubMedGoogle Scholar
  60. Hedenberg-Magnusses, B., Ernberg, M., & Koop, S. (1999). Presence of orofacial pain and temporomandibular disorders in fibromyalgia. Swedish Dental Journal, 23, 185–192.Google Scholar
  61. Hedenberg-Magnusson, B., Ernberg, M., & Kopp, S. (1997). Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontologica Scandinavica, 55, 344–349.CrossRefPubMedGoogle Scholar
  62. Hoeger-Bement, M. K., & Sluka, K. A. (2003). Phosphorylation of CREB and mechanical hyperalgesia is reversed by blockade of the cAMP pathway in a time-dependent manner after repeated intramuscular acid injections. Journal of Neuroscience, 23, 5437–5445.PubMedGoogle Scholar
  63. Hoffmann, R. G., Kotchen, J. M., Kotchen, T. A., Cowley, T., Dasgupta, M., & Cowley, A. W., Jr. (2011). Temporomandibular disorders and associated clinical comorbidities. The Clinical Journal of Pain, 27, 268–274.CrossRefPubMedGoogle Scholar
  64. Hong, C.-Z. (1994). Persistence of local twitch response with loss of conduction to and from the spinal cord. Archives of Physical Medicine and Rehabilitation, 75, 12–16.PubMedGoogle Scholar
  65. Hong, C.-Z., & Torigoe, Y. (1994). Electrophysiological charateristics of localized twitch responses in responsive taut bands of rabbit skeletal muscle. Journal of Musculoskeletal Pain, 2, 17–43.CrossRefGoogle Scholar
  66. Hubbard, D. R., & Berkoff, G. M. (1993). Myofascial trigger points show spontaneous needle EMG activity. Spine (Philadelphia, Pa. 1976), 18, 1803–1807.CrossRefGoogle Scholar
  67. Isong, U., Gansky, S. A., & Plesh, O. (2008). Temporomandibular joint and muscle disorder-type pain in U.S. adults: the National Health Interview Survey. Journal of Orofacial Pain, 22, 317–322.PubMedGoogle Scholar
  68. Jensen, M. P., & Karoly, P. (1991). Control beliefs, coping efforts, and adjustment to chronic pain. Journal of Consulting and Clinical Psychology, 59, 431–438.CrossRefPubMedGoogle Scholar
  69. Jensen, M. P., Turner, J. A., & Romano, J. M. (1991). Self-efficacy and outcome expectancies: Relationship to chronic pain coping strategies and adjustment. Pain, 44, 263–269.CrossRefPubMedGoogle Scholar
  70. Jensen, M. P., Turner, J. A., Romano, J. M., & Lawler, B. K. (1994). Relationship of pain-specific beliefs to chronic pain adjustment. Pain, 57, 301–309.CrossRefPubMedGoogle Scholar
  71. John, M. T., Miglioretti, D. L., LeResche, L., Von Korff, M., & Critchlow, C. W. (2003). Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain, 102, 257–263.CrossRefPubMedGoogle Scholar
  72. Jones, D. A., Rollman, G. B., & Brooke, R. I. (1997). The cortisol response to psychological stress in temporomandibular dysfunction. Pain, 72, 171–182.CrossRefPubMedGoogle Scholar
  73. Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain, 114, 295–302.CrossRefPubMedGoogle Scholar
  74. Kashima, K., Rahman, O. I., Sakoda, S., & Shiba, R. (1999). Increased pain sensitivity of the upper extremities of TMD patients with myalgia to experimentally-evoked noxious stimulation: Possibility of worsened endogenous opioid systems. Cranio, 17, 241–246.PubMedGoogle Scholar
  75. Katz, D. L., Greene, L., Ali, A., & Faridi, Z. (2007). The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Medical Hypotheses, 69, 517–525.CrossRefPubMedGoogle Scholar
  76. Kniffki, K. D., Mense, S., & Schmidt, R. F. (1978). Responses of group IV afferent units from skeletal muscle to stretch, contraction and chemical stimulation. Experimental Brain Research, 31, 511–522.CrossRefGoogle Scholar
  77. Komaroff, A. L., & Goldenberg, D. (1989). The chronic fatigue syndrome: Definition, current studies and lessons for fibromyalgia research. The Journal of Rheumatology. Supplement, 19, 23–27.PubMedGoogle Scholar
  78. Korszun, A., Papadopoulos, E., Demitrack, M., Engleberg, C., & Crofford, L. (1998). The relationship between temporomandibular disorders and stress-associated syndromes. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 86, 416–420.CrossRefPubMedGoogle Scholar
  79. Korszun, A., Young, E. A., Singer, K., Carlson, N. E., Brown, M. B., & Crofford, L. (2002). Basal circadian cortisol secretion in women with temporomandibular disorders. Journal of Dental Research, 81, 279–283.CrossRefPubMedGoogle Scholar
  80. Kosek, E., Ekholm, J., & Hansson, P. (1996a). Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain, 64, 415–423.CrossRefPubMedGoogle Scholar
  81. Kosek, E., Ekholm, J., & Hansson, P. (1996b). Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain, 68, 375–383.CrossRefPubMedGoogle Scholar
  82. Laske, C., Stransky, E., Eschweiler, G. W., Klein, R., Wittorf, A., Leyhe, T., Richartz, E., Kohler, N., Bartels, M., Buchkremer, G., & Schott, K. (2007). Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. Journal of Psychiatric Research, 41, 600–605.CrossRefPubMedGoogle Scholar
  83. Laskin, D., Greenfield, E., Gale, E., Ruth, J., Neff, P., Alling, C., et al. (1983). The President’s conference on the examination, diagnosis and management of temporomandibular disorders. Chicago: American Dental Association.Google Scholar
  84. Lautenbacher, S., & Rollman, G. B. (1997). Possible deficiencies of pain modulation in fibromyalgia. The Clinical Journal of Pain, 13, 189–196.CrossRefPubMedGoogle Scholar
  85. Lautenbacher, S., Rollman, G. B., & McCain, G. A. (1994). Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain, 59, 45–53.CrossRefPubMedGoogle Scholar
  86. Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., Jordan, J. M., Katz, J. N., Kremers, H. M., & Wolfe, F. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Part II. Arthritis and Rheumatism, 58, 26–35.CrossRefPubMedGoogle Scholar
  87. Leblebici, B., Pektas, Z. O., Ortancil, O., Hurcan, E. C., Bagis, S., & Akman, M. N. (2007). Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes. Rheumatology International, 27, 541–544.CrossRefPubMedGoogle Scholar
  88. Legangneux, E., Mora, J. J., Spreux-Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C. (2001). Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford, England), 40, 290–296.CrossRefGoogle Scholar
  89. LeResche, L. (1997). Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Critical Reviews in Oral Biology and Medicine, 8, 291–305.CrossRefPubMedGoogle Scholar
  90. LeResche, L., Mancl, L. A., Drangsholt, M. T., Huang, G., & Von Korff, M. (2007). Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain, 129, 269–278.CrossRefPubMedGoogle Scholar
  91. Light, K. C., Bragdon, E. E., Grewen, K. M., Brownley, K. A., Girdler, S. S., & Maixner, W. (2009). Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. The Journal of Pain, 10, 542–552.CrossRefPubMedGoogle Scholar
  92. Lim, P. F., Smith, S., Bhalang, K., Slade, G. D., & Maixner, W. (2010). Development of temporomandibular disorders is associated with greater bodily pain experience. The Clinical Journal of Pain, 26, 116–120.CrossRefPubMedGoogle Scholar
  93. Litt, M. D., Shafer, D. M., Ibanez, C. R., Kreutzer, D. L., & Tawfik-Yonkers, Z. (2009). Momentary pain and coping in temporomandibular disorder pain: exploring mechanisms of cognitive behavioral treatment for chronic pain. Pain, 145, 160–168.CrossRefPubMedGoogle Scholar
  94. Litt, M. D., Shafer, D., & Napolitano, C. (2004). Momentary mood and coping processes in TMD pain. Health Psychology, 23, 354–362.CrossRefPubMedGoogle Scholar
  95. Loeser, J. D., & Melzack, R. (1999). Pain: An overview. The Lancet, 353, 1607–1609.CrossRefGoogle Scholar
  96. Maekawa, K., Clark, G. T., & Kuboki, T. (2002). Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. The Journal of Pain, 3, 251–260.CrossRefPubMedGoogle Scholar
  97. Maekawa, K., Twe, C., Lotaif, A., Chiappelli, F., & Clark, G. T. (2003). Function of beta-adrenergic receptors on mononuclear cells in female patients with fibromyalgia. The Journal of Rheumatology, 30, 364–368.PubMedGoogle Scholar
  98. Maixner, W., Fillingim, R., Booker, D., & Sigurdsson, A. (1995). Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain, 63, 341–351.CrossRefPubMedGoogle Scholar
  99. Maixner, W., Fillingim, R., Sigurdsson, A., Kincaid, S., & Silva, S. (1998). Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain, 76, 71–81.CrossRefPubMedGoogle Scholar
  100. Mao, J., Stein, R. B., & Osborn, J. W. (1993). Fatigue in Human Jaw Muscles: A Review. Journal of Orofacial Pain, 7, 135–142.PubMedGoogle Scholar
  101. Martinez-Lavin, M. (2007). Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Research & Therapy, 9, 216.CrossRefGoogle Scholar
  102. Mayo, K. H., Ellis, E., III, & Carlson, D. S. (1988). Histochemical characteristics of masseter and temporalis muscles after 5 weeks of maxillomandibular fixation- An investigation in Macaca mulatta. Oral Surgery, Oral Medicine, and Oral Pathology, 66, 421–426.CrossRefPubMedGoogle Scholar
  103. McCain, G. A., & Tilbe, K. S. (1989). Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. The Journal of Rheumatology. Supplement, 19, 154–157.PubMedGoogle Scholar
  104. McLean, S. A., Williams, D. A., Harris, R. E., Kop, W. J., Groner, K. H., Ambrose, K., Lyden, A. K., Gracely, R. H., Crofford, L. J., Geisser, M. E., Sen, A., Biswas, P., & Clauw, D. J. (2005). Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis and Rheumatism, 52, 3660–3669.CrossRefPubMedGoogle Scholar
  105. Meeus, M., & Nijs, J. (2007). Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clinical Rheumatology, 26, 465–473.CrossRefPubMedGoogle Scholar
  106. Melzack, R. (1971). Phantom limb pain: Concept of a central biasing mechanism. Clinical Neurosurgery, 18, 188–207.PubMedGoogle Scholar
  107. Melzack, R. (1981). Myofascial trigger points: Relation to acupuncture and mechanisms of pain. Archives of Physical Medicine and Rehabilitation, 62, 114–117.PubMedGoogle Scholar
  108. Mense, S. (1993). Nociception from Skeletal Muscle in Relation to Clinical Muscle Pain. Pain, 54, 241–289.CrossRefPubMedGoogle Scholar
  109. Moldofsky, H. K. (2001). Disordered sleep in fibromyalgia and related myofascial facial pain conditions. Dental Clinics of North America, 45, 701–713.PubMedGoogle Scholar
  110. Nackley, A. G., Tan, K. S., Fecho, K., Flood, P., Diatchenko, L., & Maixner, W. (2007). Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain, 128, 199–208.CrossRefPubMedGoogle Scholar
  111. Nagakura, Y., Oe, T., Aoki, T., & Matsuoka, N. (2009). Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain, 146, 26–33.CrossRefPubMedGoogle Scholar
  112. National Institute of Dental and Craniofacial Research. (2009). Facial pain. Retrieved from: http://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/FacialPain/.
  113. Okeson, J. (1996). Differential diagnosis and management considerations of temporomandibular disorders. In J. Okeson (Ed.), Orofacial pain (pp. 113–184). Chicago: Quintessence.Google Scholar
  114. Pennacchio, E. A., Borg-Stein, J., & Keith, D. A. (1998). The incidence of pain in the muscles of mastication in patients with fibromyalgia. Journal of the Massachusetts Dental Society, 47, 8–12.PubMedGoogle Scholar
  115. Perry, F., Heller, P. H., Kamiya, J., & Levine, J. D. (1989). Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain, 39, 77–84.CrossRefPubMedGoogle Scholar
  116. Pfau, D. B., Rolke, R., Nickel, R., Treede, R. D., & Daublaender, M. (2009). Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and Fibromyalgia Syndrome. Pain, 147, 72–83.CrossRefPubMedGoogle Scholar
  117. Plesh, O., Wolfe, F., & Lane, N. (1996). The relationship between fibromyalgia and temporomandibular disorders: Prevalence and symptom severity. The Journal of Rheumatology, 23, 1948–1952.PubMedGoogle Scholar
  118. Poirot, O., Berta, T., Decosterd, I., & Kellenberger, S. (2006). Distinct ASIC currents are expressed in rat putative nociceptors and are modulated by nerve injury. Journal of Physiology, 576, 215–234.CrossRefPubMedGoogle Scholar
  119. Price, D. D., Staud, R., Robinson, M. E., Mauderli, A. P., Cannon, R., & Vierck, C. J. (2002). Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain, 99, 49–59.CrossRefPubMedGoogle Scholar
  120. Raphael, K. G., & Marbach, J. J. (2001). Widespread pain and the effectiveness of oral splints in myofascial face pain. The Journal of the American Dental Association, 132, 305–316.PubMedGoogle Scholar
  121. Rhodus, N. L., Fricton, J., Carlson, P., & Messner, R. (2003). Oral symptoms associated with fibromyalgia syndrome. The Journal of Rheumatology, 30, 1841–1845.PubMedGoogle Scholar
  122. Rolke, R., Magerl, W., Campbell, K. A., Schalber, C., Caspari, S., Birklein, F., & Treede, R. D. (2006). Quantitative sensory testing: A comprehensive protocol for clinical trials. European Journal of Pain, 10, 77–88.CrossRefPubMedGoogle Scholar
  123. Russell, I. J. (1989). Neurohormonal aspects of fibromyalgia syndrome. Rheumatic Diseases Clinics of North America, 15, 149–168.PubMedGoogle Scholar
  124. Russell, I. J., Orr, M. D., Littman, B., Vipraio, G. A., Alboukrek, D., Michalek, J. E., Lopez, Y., & MacKillip, F. (1994). Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis and Rheumatism, 37, 1593–1601.CrossRefPubMedGoogle Scholar
  125. Sarchielli, P., Mancini, M. L., Floridi, A., Coppola, F., Rossi, C., Nardi, K., Acciarresi, M., Pini, L. A., & Calabresi, P. (2007). Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. The Journal of Pain, 8, 737–745.CrossRefPubMedGoogle Scholar
  126. Schiffman, E. L., Fricton, J. R., Haley, D. P., & Shapiro, B. L. (1990). The prevalence and treatment needs of subjects with temporomandibular disorders. The Journal of the American Dental Association, 120, 295–303.PubMedGoogle Scholar
  127. Schmidt, J. E., & Carlson, C. R. (2009). A controlled comparison of emotional reactivity and physiological response in masticatory muscle pain patients. Journal of Orofacial Pain, 23, 230–242.PubMedGoogle Scholar
  128. Sessle, B. (1995a). Brainstem Mechanisms of Orofacial Pain. In J. Fricton & R. Dubner (Eds.), Orofacial Pain and Temporomandibular Disorders (pp. 43–60). New York: Raven Press.Google Scholar
  129. Sessle, B. (1995b). Masticatory Muscle Disorders: Basic Science Perspectives. In B. J. Sessle, P. S. Bryant, & R. A. Dionne (Eds.), Temporomandibular Disorders and Related Pain Conditions: Progress in Pain Research and Therapy (pp. 47–61). IASP Press: Seatle.Google Scholar
  130. Shabalina, S. A., Zaykin, D. V., Gris, P., Ogurtsov, A. Y., Gauthier, J., Shibata, K., Tchivileva, I. E., Belfer, I., Mishra, B., Kiselycznyk, C., Wallace, M. R., Staud, R., Spiridonov, N. A., Max, M. B., Goldman, D., Fillingim, R. B., Maixner, W., & Diatchenko, L. (2009). Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Human Molecular Genetics, 18, 1037–1051.CrossRefPubMedGoogle Scholar
  131. Simons, D. (1990). Muscle pain syndromes. In J. Fricton & E. Awad (Eds.), Myofascial Pain and Fibromyalgia (pp. 1–41). New York: Raven Press.Google Scholar
  132. Simons, D. G. (2008). New views of myofascial trigger points: etiology and diagnosis. Archives of Physical Medicine and Rehabilitation, 89, 157–159.CrossRefPubMedGoogle Scholar
  133. Skyba, D. A., King, E. W., & Sluka, K. A. (2002). Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain, 98, 69–78.CrossRefPubMedGoogle Scholar
  134. Skyba, D. A., Lisi, T. L., & Sluka, K. A. (2005). Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline. Pain, 119, 142–149.CrossRefPubMedGoogle Scholar
  135. Slade, G. D., Diatchenko, L., Bhalang, K., Sigurdsson, A., Fillingim, R. B., Belfer, I., Max, M. B., Goldman, D., & Maixner, W. (2007). Influence of psychological factors on risk of temporomandibular disorders. Journal of Dental Research, 86, 1120–1125.CrossRefPubMedGoogle Scholar
  136. Sluka, K. A., Kalra, A., & Moore, S. A. (2001). Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle & Nerve, 24, 37–46.CrossRefGoogle Scholar
  137. Sluka, K. A., Price, M. P., Breese, N. M., Stucky, C. L., Wemmie, J. A., & Welsh, M. J. (2003). Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain, 106, 229–239.CrossRefPubMedGoogle Scholar
  138. Sluka, K. A., Radhakrishnan, R., Benson, C. J., Eshcol, J. O., Price, M. P., Babinski, K., Audette, K. M., Yeomans, D. C., & Wilson, S. P. (2007). ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain, 129, 102–112.CrossRefPubMedGoogle Scholar
  139. Solberg Nes, L., Carlson, C. R., Crofford, L. J., de Leeuw, R., & Segerstrom, S. C. (2010). Self-regulatory deficits in fibromyalgia and temporomandibular disorders. Pain, 151, 37–44.CrossRefPubMedGoogle Scholar
  140. Ta, L., Phero, J., Pillemer, S., Hale-Donze, H., McCartney-Francis, N., Kingman, A., Max, M., Gordon, S., Wahl, S., & Dionne, R. (2002). Clinical evaluation of patients with temporomandibular joint implants. Journal of Oral and Maxillofacial Surgery, 60, 1389–1399.CrossRefPubMedGoogle Scholar
  141. Travell, J. S. D. (1998). Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams & Wilkins Co.Google Scholar
  142. Truelove, E. L., Sommers, E. E., LeResche, L., Dworkin, S. F., & Von Korff, M. (1992). Clinical diagnostic criteria for TMD. New classification permits multiple diagnoses. The Journal of the American Dental Association, 123, 47–54.PubMedGoogle Scholar
  143. Turner, J. A., & Aaron, L. A. (2001). Pain-related catastrophizing: What is it? The Clinical Journal of Pain, 17, 65–71.CrossRefPubMedGoogle Scholar
  144. Turner, J. A., Brister, H., Huggins, K., Mancl, L., Aaron, L. A., & Truelove, E. L. (2005). Catastrophizing is associated with clinical examination findings, activity interference, and health care use among patients with temporomandibular disorders. Journal of Orofacial Pain, 19, 291–300.PubMedGoogle Scholar
  145. Turner, J. A., Dworkin, S. F., Mancl, L., Huggins, K. H., & Truelove, E. L. (2001). The roles of beliefs, catastrophizing, and coping in the functioning of patients with temporomandibular disorders. Pain, 92, 41–51.CrossRefPubMedGoogle Scholar
  146. Uhlig, Y. (1995). Fiber composition and fiber transformation in neck muscles of patients with dysfunction of the cervical spine. Journal of Orthopaedic Research, 13, 240–249.CrossRefPubMedGoogle Scholar
  147. Vaeroy, H., Helle, R., Forre, O., Kass, E., & Terenius, L. (1988). Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain, 32, 21–26.CrossRefPubMedGoogle Scholar
  148. Velly, A. M., Gornitsky, M., & Philippe, P. (2002). A case-control study of temporomandibular disorders: Symptomatic disc displacement. Journal of Oral Rehabilitation, 29, 408–416.CrossRefPubMedGoogle Scholar
  149. Velly, A. M., Gornitsky, M., & Philippe, P. (2003). Contributing factors to chronic myofascial pain: A case-control study. Pain, 104, 491–499.CrossRefPubMedGoogle Scholar
  150. Velly, A. M., Look, J. O., Schiffman, E., Lenton, P. A., Kang, W., Messner, R. P., Holcroft, C. A., & Fricton, J. R. (2010). The effect of fibromyalgia and widespread pain on the clinically significant temporomandibular muscle and joint pain disorders–a prospective 18-month cohort study. Journal of pain, 11, 1155–1164.CrossRefPubMedGoogle Scholar
  151. Von Korff, M., Dworkin, S. F., Le Resche, L., & Kruger, A. (1988). An epidemiologic comparison of pain complaints. Pain, 32, 173–183.CrossRefGoogle Scholar
  152. Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997a). A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis and Rheumatism, 40, 1560–1570.CrossRefPubMedGoogle Scholar
  153. Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997b). Work and disability status of persons with fibromyalgia. The Journal of Rheumatology, 24, 1171–1178.PubMedGoogle Scholar
  154. Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Research (Hoboken), 62, 600–610.CrossRefGoogle Scholar
  155. Wolfe, F., Hawley, D. J., Cathey, M. A., Caro, X., & Russell, I. J. (1985). Fibrositis: symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. The Journal of Rheumatology, 12, 1159–1163.PubMedGoogle Scholar
  156. Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995). The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism, 38, 19–28.CrossRefPubMedGoogle Scholar
  157. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism, 33, 160–172.CrossRefPubMedGoogle Scholar
  158. Woolf, CJ. (2010). Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 152(3), S2–15Google Scholar
  159. Wright, A. R., Gatchel, R. J., Wildenstein, L., Riggs, R., Buschang, P., & Ellis, E., 3rd. (2004). Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. Journal of American Dental Association, 135, 474–483.Google Scholar
  160. Yunus, M. B. (1992). Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation. Journal of Rheumatology, 19, 846–850.PubMedGoogle Scholar
  161. Yunus, M. B. (2008). Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Seminars in Arthritis Rheumatism, 37, 339–352.CrossRefPubMedGoogle Scholar
  162. Yunus, M. B., Kalyan-Raman, U. P., Kalyan-Raman, K., & Masi, A. T. (1986). Pathologic changes in muscle in primary fibromyalgia syndrome. American Journal of Medicine, 81, 38–42.CrossRefPubMedGoogle Scholar
  163. Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Stohler, C. S., & Goldman, D. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 299, 1240–1243.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Ana Mirian Velly
    • 1
    • 2
  • Hong Chen
    • 3
  • João R. Ferreira
    • 4
  • James R. Fricton
    • 5
  1. 1.Department of Dentistry, Centre for Clinical Epidemiology and Community StudiesJewish General HospitalMontréalCanada
  2. 2.Department of Diagnostic and Biological Sciences, Division of TMD and Orofacial PainUniversity of MinnesotaMinneapolisUSA
  3. 3.Center for Neurosensory Disorders, Orofacial Pain ClinicUniversity of North Carolina - Chapel Hill, School of DentistryChapel HillUSA
  4. 4.NC Oral Health InstituteUniversity of North Carolina, School of DentistryChapel HillUSA
  5. 5.University of MinnesotaMinneapolisUSA

Personalised recommendations